Jenny Y. Zhou, MD
- Hematologist
- Director of Hereditary Hemorrhagic Telangiectasia (HHT) Center
- Assistant Professor of Medicine
At UC San Diego Health, you'll find experts who can diagnose and help you proactively manage hereditary hemorrhagic telangiectasia (HHT).
Our program is designated as a Center of Excellence by Cure HHT. We are one of only four recognized centers on the West Coast and among 32 across North America. Patients travel to our center from across California, as well as Arizona and Nevada, to get care for HHT.
Led by Dr. Jenny Zhou, our team includes medical specialists who are knowledgeable about the unique symptoms and treatment options for the disease.
HHT is an inherited condition that causes malformed blood vessels and pulmonary arteriovenous malformations (PAVM). The most common locations affected are the nose, lungs, brain and liver.
Early diagnosis and treatment can help prevent serious complications.
An estimated 90% of those with HHT go undiagnosed, so it's important that you recognize common signs and symptoms of the disorder:
If you have signs and symptoms of HHT, we strongly recommend that you undergo a thorough screening and consultation to make sure your condition is correctly diagnosed and treated. Based on your health history, your screening may include:
We offer comprehensive treatment options to address all the different parts of the body that the disorder may affect, including: